Antibodies (9)

Igovomab

Reference: HY-P9943

€0.00 (tax incl.)

Igovomab is a monoclonal antibody for imaging. Igovomab can be used for ovarian cancer research.

Girentuximab

Reference: HY-P99023

€0.00 (tax incl.)

Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC).

Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity....

Raleukin

Reference: HY-108841

€0.00 (tax incl.)

Raleukin (AMG-719) is a recombinant, nonglycosylated human interleukin-1 receptor (IL-1R) antagonist. Raleukin (AMG-719) is the first biological agent to block the pro-inflammatory effects.

Anti-Mouse IL-1b Antibody

Reference: HY-P99139

€0.00 (tax incl.)

Anti-Mouse IL-1b Antibody is an anti-mouse IL-1b IgG antibody inhibitor derived from host Armenian Hamster.

Teneliximab

Reference: HY-P99321

€0.00 (tax incl.)

Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell...

Anti-Mouse CD90.2 Antibody

Reference: HY-P99131

€0.00 (tax incl.)

Anti-Mouse CD90.2 Antibody is an anti-mouse CD90.2 IgG2b antibody inhibitor derived from host Rat.

Livmoniplimab

Reference: HY-P99708

€0.00 (tax incl.)

Livmoniplimab (ABBV-151; ARGX-115) is a potent humanized anti-LRRC32 (GARP)/TGFβ1 monoclonal antibody. Livmoniplimab blocks LRRC32-mediated activation of latent TGFβ1. Livmoniplimab has the potential for the research...

Tixagevimab

Reference: HY-P99556

€0.00 (tax incl.)

Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein...

Inezetamab

Reference: HY-P99663

€0.00 (tax incl.)

Inezetamab is a bispecific anti-CD40 and anti-MSLN IgG1 monoclonal antibody.

Tamtuvetmab

Reference: HY-P99579

€0.00 (tax incl.)

Tamtuvetmab (AT-005) is a caninised blontuvetmab against CD52. Tamtuvetmab increases progression-free survival (PFS), exhibits in vivo efficacy in dogs with naïve T-cell lymphoma (LSA). Tamtuvetmab has been approved...

Veltuzumab

Reference: HY-P99224

€0.00 (tax incl.)

Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin...

Lanadelumab

Reference: HY-P99110

€0.00 (tax incl.)

Lanadelumab (SHP643) is a humanized IgG1 monoclonal antibody against plasma kallikrein (pKal) with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK (high molecular weight kininogen)-bound pKal....

Enoblituzumab

Reference: HY-P9966

€0.00 (tax incl.)

Enoblituzumab (MGA271) is a humanized IgG1κ monoclonal antibody recognizing human B7-H3 protein, a member of the B7 family of immune regulators.

Clervonafusp alfa

Reference: HY-P99803

€0.00 (tax incl.)

Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha...

Magrolimab

Reference: HY-P99029

€0.00 (tax incl.)

Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity.

Trinbelimab

Reference: HY-P99545

€0.00 (tax incl.)

Trinbelimab (r-anti-D) is an antibody. Trinbelimab can be used for various biochemical studies.

Cirevetmab

Reference: HY-P99606

€0.00 (tax incl.)

Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator.

Pavurutamab

Reference: HY-P99814

€0.00 (tax incl.)

Pavurutamab (AMG-701) is a bispecific T cell engager molecule that anti-CD3 and anti-B cell maturation antigens (BCMA). Pavurutamab has an extended half-life based on Pacanalotamab (HY-P99798). The Fc of Pavurutamab...

Firivumab

Reference: HY-P99620

€0.00 (tax incl.)

Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows...

Anti-SARS-CoV-2 Spike mAb (CR3022)

Reference: HY-P9807

€0.00 (tax incl.)

Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein.

Idactamab

Reference: HY-P99654

€0.00 (tax incl.)

Idactamab (INT-001) is an IgG1-κ antibody with in vivo activity across a spectrum of hematological malignancies. Idactamab can be used for prepare MEDI7247, a potent and specific ADC, targeting ASCT2 (SLC1A5).

Vepsitamab

Reference: HY-P99523

€0.00 (tax incl.)

Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation.

Tidutamab

Reference: HY-P99562

€0.00 (tax incl.)

Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum...

Mitazalimab

Reference: HY-P99742

€0.00 (tax incl.)

Mitazalimab (ADC-1013; JNJ-64457107) is FcγR-dependent CD40 agonist with tumor-directed activity. Mitazalimab activates antigen-presenting cells, e.g. dendritic cells (DC), to initiate tumor-reactive T cells....

Teropavimab

Reference: HY-P99564

€0.00 (tax incl.)

Teropavimab (3BNC117-LS) is an antibody. Teropavimab can be used for the research of HIV infection.

Bertilimumab

Reference: HY-P99474

€0.00 (tax incl.)

Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11). Bertilimumab has the potential for allergic disorders research.

Izokibep

Reference: HY-P99678

€0.00 (tax incl.)

Izokibep (ABY-035) is a selective and antibody mimetic interleukin 17A (IL-17A) inhibitor with high potency and long half-life. Izokibep can be used for the research of ankylosing spondylitis, atherosclerosis and skin...

Blontuvetmab

Reference: HY-P99483

€0.00 (tax incl.)

Blontuvetmab (AT 004)is a caninized CD20 monoclonal antibody. Blontuvetmab can be used for the research of Canine B-cell lymphoma.

Tucotuzumab

Reference: HY-P99328

€0.00 (tax incl.)

Tucotuzumab (Anti-EPCAM Recombinant Antibody) is a protein composed of an IgG1 monoclonal antibody specific for the human Epithelial Cell Adhesion Molecule (EpCAM) antigen, linked to two molecules of IL-2. Tucotuzumab...

Imdevimab

Reference: HY-P99342

€0.00 (tax incl.)

Imdevimab (REGN10987) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab...

Befovacimab

Reference: HY-P99465

€0.00 (tax incl.)

Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research.

Prasinezumab

Reference: HY-P99405

€0.00 (tax incl.)

Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research.

Vopratelimab

Reference: HY-P99382

€0.00 (tax incl.)

Vopratelimab (JTX-2011) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab retains species cross-reactivity with...

Icrucumab

Reference: HY-P99364

€0.00 (tax incl.)

Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a humanized Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors.

Ieramilimab

Reference: HY-P99027

€0.00 (tax incl.)

Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules.

Sudubrilimab

Reference: HY-P99963

€0.00 (tax incl.)

Sudubrilimab (HS636) is an Ig G1-kappa monoclonal antibody against PDL1. Sudubrilimab is fused at the C terminus of the heavy chain to a TGF-β1 receptor Ⅱ ectodomain (TGFBR2-ECD), and which can sequester the...

Batiraxcept

Reference: HY-P99463

€0.00 (tax incl.)

Batiraxcept (AVB-S6-500) is a highly potent and specific AXL inhibitor, a recombinant fusion protein dimer containing the extracellular domain of human AXLM and human immunoglobulin G1 heavy chain (Fc). Batiraxcept...

Disitamab

Reference: HY-P99854

€0.00 (tax incl.)

Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2. Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs), Disitamab vedotin (Disitamab vedotin (HY-P9985)).

Zampilimab

Reference: HY-P99512

€0.00 (tax incl.)

Zampilimab (UCB-7858) is a monoclonal antibody against transglutaminase 2 (TG2). Zampilimab has potential application in renal transplant.

CTX-471

Reference: HY-P99178

€0.00 (tax incl.)

CTX-471 is a fully human monoclonal antibody of CD137. CTX-471 has bind affinity for recombinant human, cynomolgus macaque CD137 and mouse CD137 with Kd values of 50 nM, 61 nM and 748 nM, respectively. CTX-471 can be...

Latikafusp

Reference: HY-P99687

€0.00 (tax incl.)

Latikafusp (AMG 256) is a bifunctional fusion protein comprising a PD-1-targeting antibody and IL-21 mutein designed to deliver IL-21 pathway stimulation to PD-1+ cells. Latikafusp is designed to prime and extend the...

Simtuzumab

Reference: HY-P99047

€0.00 (tax incl.)

Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC).

Orticumab

Reference: HY-P99793

€0.00 (tax incl.)

Orticumab (MLDL1278A) is an antibody targeting to oxidized or malondialdehyde-modified lipoprotein (LDL). Orticumab specifically inhibits oxidized low-density lipoproteins (oxLDL). Orticumab involves in modulation of...

Geptanolimab

Reference: HY-P99639

€0.00 (tax incl.)

Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research...

Naptumomab

Reference: HY-P99035

€0.00 (tax incl.)

Naptumomab, a tumor targeting superantigen (TTS), is a fusion protein containing. Naptumomab stimulates the immune system to identify and kill tumour cells. Naptumomab can be used for the research of refractory solid...

Teclistamab

Reference: HY-P99392

€0.00 (tax incl.)

Teclistamab is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell...

Crovalimab

Reference: HY-P99965

€0.00 (tax incl.)

Crovalimab (SKY59; RO7112689) is a novel humanized antibody against C5 in a pH-dependent manner with KDs of 15.2 nM and 16.8 μM at pH 7.4 and 5.8, respectively. Crovalimab binds human FcRn with great affinity (KD: 17...

Trastuzumab beta

Reference: HY-P99548

€0.00 (tax incl.)

Trastuzumab beta (ABP 980) is a biosimilar to Trastuzumab (HY-P9907). Trastuzumab beta is a monoclonal antibody (McAb) targeting human epidermal growth factor receptor 2 (HER2). Trastuzumab beta can be used for the...

Gatipotuzumab

Reference: HY-P99634

€0.00 (tax incl.)

Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC).

Flanvotumab

Reference: HY-P99622

€0.00 (tax incl.)

Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated...

Inotuzumab

Reference: HY-P99264

€0.00 (tax incl.)

Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can...

Temelimab

Reference: HY-P99567

€0.00 (tax incl.)

Temelimab (GNbAC-1) is an IgG4 monoclonal antibody that targets the human endogenous retroviral envelope protein HERV-W-Env.

Quisovalimab

Reference: HY-P99810

€0.00 (tax incl.)

Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome...

Adecatumumab

Reference: HY-P99278

€0.00 (tax incl.)

Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is...

Perakizumab

Reference: HY-P99310

€0.00 (tax incl.)

Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis.

Romosozumab

Reference: HY-P9982

€0.00 (tax incl.)

Romosozumab is a humanized monoclonal anti-sclerostin antibody, it promotes bone formation and inhibits bone resorption by inhibiting sclerostin. Romosozumab can be used for the research of osteoporosis.

Anti-Mouse CD11b Antibody

Reference: HY-P99121

€0.00 (tax incl.)

Anti-Mouse CD11b Antibody is an anti-mouse CD11b IgG2b antibody inhibitor derived from the host Rat.

Tilavonemab

Reference: HY-P99163

€0.00 (tax incl.)

Tilavonemab (ABBV-8E12) is a humanised anti-tau antibody that binds amino acids 25-30 near the N-terminal end of the tau protein. Tilavonemab blocks the ability of human and mouse neurons to take up tau aggregates and...

Cosfroviximab

Reference: HY-P99832

€0.00 (tax incl.)

Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP).

Human IgG2 kappa, Isotype Control

Reference: HY-P99002

€0.00 (tax incl.)

Human IgG2 kappa, Isotype Control, a human monoclonal antibody, is an isotype control for human IgG2κ antibody.

Seletracetam lithium

Reference: HY-119810A

€0.00 (tax incl.)

Seletracetam (Ucb 44212) lithium, as an analog of the antiepileptic agent Levetiracetam, is a SV2A modulator for the research of epilepsy.

Ledelabricin alfa

Reference: HY-P99690

€0.00 (tax incl.)

Ledelabricin alfa is a human proteoglycan 4 (PRG4) isoform A variant. PRG4 is a joint/boundary lubricant. Ledelabricin Alfa can be used for the research arthropathy.

Nerelimomab

Reference: HY-P99753

€0.00 (tax incl.)

Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis.

Obiltoxaximab

Reference: HY-P9932

€0.00 (tax incl.)

Obiltoxaximab is a potent anti-protective antigen (PA) monoclonal antibody. Obiltoxaximab plays a central role in anthrax toxin assembly and target cell intoxication. Obiltoxaximab can be used in animal‐to‐human dose...

Category: Antibodies

Menu

Settings